All articles by BV Swagath
BV Swagath
PTC Therapeutics` Upstaza receives FDA priority review for AADC deficiency
PTC Therapeutics said that the biologics license application (BLA) for its gene therapy candidate Upstaza (eladocagene exuparvovec) has been accepted…
Verismo Therapeutics receives IND clearance from the FDA for SynKIR-310 in relapsed/refractory B-cell NHL
Verismo Therapeutics, a clinical-stage CAR T company developing the novel KIR-CAR platform technology, announced that it has received a notification…
Gilgamesh, AbbVie strike deal worth up to $2bn for psychiatric therapies
Gilgamesh Pharmaceuticals has secured a collaboration and option-to-licence deal worth up to $2.01bn with AbbVie to research and develop next-generation…
Fulcrum Therapeutics, Sanofi ink deal worth up to $1bn for losmapimod development
Fulcrum Therapeutics has signed a collaboration and licensing deal worth up to $1.05bn for the development and commercialisation of its…
Boehringer Ingelheim expands access to adalimumab-adbm injection, the company`s biosimilar to Humira
Boehringer Ingelheim announced an agreement with Quallent Pharmaceuticals, a private label pharmaceutical distributor, to help expand patient access to citrate-free…
Pfizer’s Emblaveo gets EC approval for treatment of multidrug-resistant infections
Pfizer’s Emblaveo (aztreonam-avibactam) has secured marketing authorisation from the European Commission (EC) for the treatment of adult patients with multidrug-resistant…
Ochre Bio, Boehringer Ingelheim to join forces to develop RNA therapeutics for CLDs
Ochre Bio, a UK-based biotechnology firm, engaged in developing ribonucleic acid (RNA) therapeutics for undertreated chronic liver diseases, has forged…
ImmunityBio’s Anktiva gains FDA approval for BCG-unresponsive NMIBC
ImmunityBio has secured approval for Anktiva (N-803, or nogapendekin alfa inbakicept-pmln) in combination with Bacillus Calmette-Guérin (BCG) from the US…
Lilly acquires new injectable medicine manufacturing facility from Nexus Pharmaceuticals
Eli Lilly and Company (NYSE: LLY) and Nexus Pharmaceuticals, LLC announced a definitive agreement for Lilly to acquire a manufacturing…
Awiqli recommended for approval for the treatment of diabetes by the European regulatory authorities
Novo Nordisk announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive…